Clinical trials
Terminated trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,098 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 6 |
| 2005 | 9 |
| 2006 | 9 |
| 2007 | 25 |
| 2008 | 29 |
| 2009 | 29 |
| 2010 | 48 |
| 2011 | 42 |
| 2012 | 68 |
| 2013 | 59 |
| 2014 | 69 |
| 2015 | 62 |
| 2016 | 56 |
| 2017 | 73 |
| 2018 | 86 |
| 2019 | 74 |
| 2020 | 90 |
| 2021 | 106 |
| 2022 | 71 |
| 2023 | 50 |
| 2024 | 27 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 1,098 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 63 |
| Seoul National University Hospital | 49 |
| Hoffmann-La Roche | 47 |
| Pfizer | 43 |
| GlaxoSmithKline | 33 |
| Sanofi | 33 |
| Yonsei University | 30 |
| AstraZeneca | 29 |
| Amgen | 24 |
| Asan Medical Center | 24 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 75 |
| Neoplasms | 51 |
| Breast Neoplasms | 40 |
| Neoplasm Metastasis | 37 |
| Alzheimer Disease | 32 |
| Coronary Artery Disease | 32 |
| Colorectal Neoplasms | 30 |
| Stomach Neoplasms | 30 |
| Recurrence | 25 |
| Carcinoma, Hepatocellular | 23 |
Trials
Showing 1 to 25 of 1,098. Each trial links to its page on Pharma Observatory.
998 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.